Missed Opportunities for Antifungal Stewardship during the COVID-19 Era
Significant increases in antibacterial use were observed during the COVID-19 pandemic. However, subsequent analyses found this increase in antibiotic use to be excessive in comparison with the relatively low rates of bacterial coinfection. Although patients who are critically ill with COVID-19 may b...
Main Authors: | Brandon K. Hawkins, Samantha D. Walker, Mahmoud A. Shorman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/9/1352 |
Similar Items
-
The Current State of Antifungal Stewardship in Immunocompromised Populations
by: William Alegria, et al.
Published: (2021-04-01) -
Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
by: Yuki Moriyama , et al.
Published: (2021-04-01) -
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
by: Behnam Honarvar, et al.
Published: (2018-12-01) -
Challenges and research priorities to progress the impact of antimicrobial stewardship
by: Matteo Bassetti, et al.
Published: (2019-08-01) -
The Impact of Antifungal Stewardship on Clinical and Performance Measures: A Global Systematic Review
by: Fares Albahar, et al.
Published: (2023-12-01)